Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPRENAVIR vs ANAKINRA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPRENAVIR vs ANAKINRA: Safety Overview

Metric AMPRENAVIR ANAKINRA
Total FAERS Reports 109 12,145
Deaths Reported 4 979
Death Rate 3.7% 8.1%
Hospitalizations 16 3,472
Average Patient Age 44.0 yrs 39.2 yrs
% Female Patients 25.0% 66.3%
FDA Approval Date Apr 15, 1999 N/A
Manufacturer N/A Swedish Orphan Biovitrum AB (publ)
Route N/A SUBCUTANEOUS
Marketing Status Discontinued Prescription